Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03947619 · ClinicalTrials.gov registry record · NA
Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial
A NA study of ST Elevation (STEMI) Myocardial Infarction of Anterior Wall, sponsored by Abiomed.
- Active
- Registry status
- NA
- Development phase
- 527
- Enrollment target
- 20
- Study locations
NCT03947619 is a NA study of ST Elevation (STEMI) Myocardial Infarction of Anterior Wall that is active but no longer recruiting, run by Abiomed. The registered enrollment target is 527 participants. The trial reports 20 study locations across 11 states.
The verdict
NCT03947619, a NA study of ST Elevation (STEMI) Myocardial Infarction of Anterior Wall, is active but no longer recruiting, sponsored by Abiomed.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 527 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this research study is to evaluate whether using the the IMPELLA® CP System temporary circulatory assist device for 30 minutes prior to a catheterization procedure has the potential to reduce the damage to the heart caused by a heart attack, compared to the current standard of care.
Conditions Studied
Interventions
- DEVICE Impella CP® placement prior to reperfusion with Primary PCI
Study Locations (20)
Florida
- BayCare Cardiology - Morton Plant Hospital - Clearwater
- Baptist Health Research Institute - Jacksonville
- Tallahasse Research Institute - Tallahassee
- AdventHealth - Tampa - Tampa
Illinois
- North Shore University Health System - Evanston
- Midwest Cardiovascular Institute - Naperville
- OSF Saint Francis - Peoria
- Southern Illinois University School of Medicine - Springfield
Arizona
- HonorHealth Research Institute - Scottsdale
- The University of Arizona - Tucson
California
- Emanate Health Intercommunity Hospital / Valley Clinical Trials, Inc. - Covina
- Riverside Community Hospital - Riverside
Georgia
- Northside Hospital - Atlanta
- Wellstar/Kennestone Hospital - Marietta
Alabama
- University of Alabama at Birmingham - Birmingham
Colorado
- St. Anthony Hospital - Lakewood
Connecticut
- Hartford Health Care - Hartford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 527 participants |
| Start Date | 2019-12-12 |
| Est. Completion | 2030-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03947619
The ClinicalTrials.gov registry entry for NCT03947619 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 527 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abiomed, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with ST Elevation (STEMI) Myocardial Infarction of Anterior Wall appearing as the primary indexed condition, and to 1 intervention - of which Impella CP® placement prior to reperfusion with Primary PCI is the first listed.
NCT03947619 reports 20 study locations spanning 11 distinct geographic areas - top geographies include Florida, Illinois, Arizona.
Frequently Asked Questions
What is clinical trial NCT03947619 about?
NCT03947619 is a clinical study titled "Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial". The purpose of this research study is to evaluate whether using the the IMPELLA® CP System temporary circulatory assist device for 30 minutes prior to a catheterization procedure has the potential to reduce the damage to the heart caused by a heart attack, compared to the current standard of care.
What is the current status of trial NCT03947619?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 527 participants. The study started on 2019-12-12. Estimated completion is 2030-10.
What conditions does trial NCT03947619 study?
This clinical trial studies the following conditions: ST Elevation (STEMI) Myocardial Infarction of Anterior Wall.
What interventions are being tested in trial NCT03947619?
The interventions under investigation include: Impella CP® placement prior to reperfusion with Primary PCI (DEVICE).
Who is sponsoring clinical trial NCT03947619?
This trial is sponsored by Abiomed, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03947619 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.